Motagon says the import is a unique medical cannabis frontier with immense potential.
Italy could join Austria and Cyprus as one of the only countries to allow home cultivation for medicinal use.
The development will give hope to cancer patients as current treatment options for cancer-related pain are largely ineffective.
The products are set to be made available to patients in the coming weeks
Swiss Life Sciences says it aims to improve on cannabis medicines that are already being successfully used in treatments with elite genetics.
The exclusive agreement will enable the distribution of Panaxia's advanced medical cannabis products in Poland.
Flowr will be growing some of the most recognisable cannabis strains in the world, including Gelatti and Pink Runtz, in Portugal.
Extracts are currently the fastest growing product in the German medical cannabis market.
The products will benefit European patients with rapid on-set effects within five to 15 minutes alongside improved absorption efficiency.
Cleaver Leaves has announced it will be supporting The University of Missouri by providing CBD isolate at no cost.
